Protuoso Biosciences, a US-headquartered biotechnology company developing multifunctional biologic therapies, has raised US$9.5 million in an oversubscribed seed financing round led by Taiwanese VC fund companies Taya Venture and Darwin Ventures, with participation from NSG Ventures, SEEDS and other investors. […]
The number of haze-related illness cases showed a downward trend in Epidemiological Week (EW) 37/2026... Read More
More than 55,000 civil servants screened under a digital health profiling system have been identified as being high-risk for mental... Read More
Type 2 diabetes has been detected among Malaysians at an increasingly young age, with the disease detected in children... Read More
The Ministry of Health (MOH) is still conducting comprehensive studies and evaluations before making the dengue... Read More
Private hospitals are seeing an increase in dengue admissions this year, mirroring trends at public hospitals... Read More
Building a dementia-ready Malaysia by 2030 requires coordinated efforts from communities alongside government... Read More
The care economy goes beyond welfare and charity and is a revenue-generating sector cutting across employment... Read More
Healthcare professionals, buyers, and industry leaders from across the globe will gather in Bangkok from 10 to 12 September 2025... Read More
As we strive to be the hospital of choice, why not refine our commitment to excellence beyond the pivotal mission of saving lives... Read More